April 11, 2025 - 21:20

Hamamatsu Photonics has announced a significant strategic partnership with Sirona Dx (SDX) aimed at expanding their Technology Access Program (TAP). This collaboration is set to enhance the accessibility of cutting-edge imaging and proteomics solutions, which are crucial for advancing research and diagnostics in various fields.
The partnership will leverage Hamamatsu's expertise in whole slide imaging and spatial proteomics, enabling researchers and healthcare professionals to benefit from innovative technologies that improve diagnostic accuracy and efficiency. By combining resources and knowledge, both companies aim to drive advancements in the medical and research communities.
This initiative is expected to facilitate better access to high-quality imaging tools, ultimately leading to improved patient outcomes and accelerated scientific discovery. The collaboration reflects a commitment to fostering innovation and ensuring that state-of-the-art technology is available to a broader audience, paving the way for future breakthroughs in healthcare and research.
May 25, 2026 - 23:35
Pope calls for AI regulation, using technology for common good rather than profitPope Leo XIV issued a powerful call for global regulation of artificial intelligence on Monday, urging developers and governments to prioritize the common good over corporate profits. In a...
May 25, 2026 - 07:17
ANT Systems Launches Industrial-Scale Production of Drought Technology Used on Five ContinentsISTANBUL, Türkiye -- Agricultural nano-technology company ANT Systems has announced the start of industrial-scale production of NANOTERN, a biodegradable water-retention material made from...
May 24, 2026 - 23:42
POET Technologies: Great Technology, Terrible InvestmentPOET Technologies, once a high-flying name in the photonics space, has been handed a Sell rating by analysts who see little near-term payoff for investors. The core issue is a stark mismatch...
May 24, 2026 - 04:15
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the BunchThe first quarter earnings season has now drawn to a close for the healthcare technology for providers sector, and the results paint a clear picture of which companies are thriving and which are...